A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity. (Q40509217)
Jump to navigation
Jump to search
scientific article published on June 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity. |
scientific article published on June 2004 |
Statements
A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity (English)
Beatrice Jahn-Schmid
Uwe B Sleytr
Margit Sára
Andreas Breitwieser
Bettina Zwölfer